KRISTIN GARCIA: Open Payments
NPI 1730895434 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 48 payments from 12 companies in 2025. Trend: 2023 $1,949 · 2024 $708 · 2025 $1,024
Food & beverage: $957Education: $68
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $215 |
| Sumitomo Pharma America, Inc. | 7 | $170 |
| ABBVIE INC. | 9 | $168 |
| Exeltis, USA Inc. | 6 | $160 |
| Biogen, Inc. | 6 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| MILLICENT US INC | 2 | $40 |
| Organon LLC | 2 | $39 |
| PFIZER INC. | 1 | $18 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
Products named: GEMTESA, BOTOX, Veozah, ZURZUVAE, TWIRLA, Mirena, SLYND, NEXPLANON.
Industry payments across AR — which companies pay providers there.
